Van Lanschot Kempen Life Sciences Conference Amsterdam Investor conference Company management will be conducting investor meetings at the Van Lanschot Kempen Life Sciences Conference Amsterdam on April 26. April 26, 2023
RNA Editing Gordon Research Conference (GRC) Presentation ProQR Presentation at the RNA Editing Gordon Research Conference (GRC) March 23, 2023
RNA Leaders Europe Congress Presentation ProQR Presentation at RNA Leaders Europe Congress March 16, 2023
Oligonucleotide and Precision Therapeutics (OPT) Congress Congress ProQR presentation and panel session at the Oligonucleotide and Precision Therapeutics (OPT) Congress March 14, 2023
ProQR Therapeutics Virtual R&D Event 2023 Webcast On March 29, 2023 ProQR will host a virtual R&D event to showcase its proprietary Axiomer RNA-editing technology platform. ProQR will also announce initial pipeline targets for internal development. March 29, 2023
ProQR Investor/Analyst Webcast: Lilly Partnership Expansion and Axiomer Overview Webcast With the announcement of the expansion of ProQR and Lilly's partnership, ProQR Management is hosting a conference call. December 22, 2022
TIDES Europe - Oligonucleotide and Peptide Therapeutics Conference Congress ProQR to present at the TIDES Europe conference on oligonucleotide and peptide therapeutics in Vienna, Austria and online. November 16, 2022
Stifel 2022 Healthcare Conference Investor conference ProQR is participating in the Stifel 2022 Healthcare Conference. November 16, 2022
Investor Call Webcast ProQR to Focus Exclusively on Axiomer RNA-editing Technology and Partner Ophthalmology Programs - Management Call August 11, 2022
Life Sci 2nd Annual Genetic Medicines Symposium Webcast ProQR's participation in the Life Sci 2nd Annual Genetic Medicines Symposium June 29, 2022